Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • Resource and Technical Advances
    • Clinical Medicine
    • Reviews
    • Editorials
    • Perspectives
    • Top read articles
  • JCI This Month
    • Current issue
    • Past issues

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Concise Communication
  • Editorials
  • Viewpoint
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Transfers
  • Advertising
  • Job board
  • Contact
The hepatic WASH complex is required for efficient plasma LDL and HDL cholesterol clearance
Melinde Wijers, … , Jan Albert Kuivenhoven, Bart van de Sluis
Melinde Wijers, … , Jan Albert Kuivenhoven, Bart van de Sluis
Published June 6, 2019
Citation Information: JCI Insight. 2019;4(11):e126462. https://doi.org/10.1172/jci.insight.126462.
View: Text | PDF | Corrigendum
Research Article Hepatology Metabolism

The hepatic WASH complex is required for efficient plasma LDL and HDL cholesterol clearance

  • Text
  • PDF
Abstract

The evolutionary conserved Wiskott-Aldrich syndrome protein and SCAR homolog (WASH) complex is one of the crucial multiprotein complexes that facilitates endosomal recycling of transmembrane proteins. Defects in WASH components have been associated with inherited developmental and neurological disorders in humans. Here, we show that hepatic ablation of the WASH component Washc1 in chow-fed mice increases plasma concentrations of cholesterol in both LDLs and HDLs, without affecting hepatic cholesterol content, hepatic cholesterol synthesis, biliary cholesterol excretion, or hepatic bile acid metabolism. Elevated plasma LDL cholesterol was related to reduced hepatocytic surface levels of the LDL receptor (LDLR) and the LDLR-related protein LRP1. Hepatic WASH ablation also reduced the surface levels of scavenger receptor class B type I and, concomitantly, selective uptake of HDL cholesterol into the liver. Furthermore, we found that WASHC1 deficiency increases LDLR proteolysis by the inducible degrader of LDLR, but does not affect proprotein convertase subtilisin/kexin type 9–mediated LDLR degradation. Remarkably, however, loss of hepatic WASHC1 may sensitize LRP1 for proprotein convertase subtilisin/kexin type 9–induced degradation. Altogether, these findings identify the WASH complex as a regulator of LDL as well as HDL metabolism and provide in vivo evidence for endosomal trafficking of scavenger receptor class B type I in hepatocytes.

Authors

Melinde Wijers, Paolo Zanoni, Nalan Liv, Dyonne Y. Vos, Michelle Y. Jäckstein, Marieke Smit, Sanne Wilbrink, Justina C. Wolters, Ydwine T. van der Veen, Nicolette Huijkman, Daphne Dekker, Niels Kloosterhuis, Theo H. van Dijk, Daniel D. Billadeau, Folkert Kuipers, Judith Klumperman, Arnold von Eckardstein, Jan Albert Kuivenhoven, Bart van de Sluis

×

Figure 5

Hepatic uptake of HDL-C is impaired by reduced surface levels of SR-BI in hepatic WASH-deficient mice.

Options: View larger image (or click on image) Download as PowerPoint
Hepatic uptake of HDL-C is impaired by reduced surface levels of SR-BI i...
(A) Immunoblot of whole-cell and cell-surface SR-BI levels in WT and Washc1–/– primary hepatocytes. (B) Plasma hepatic lipase levels of male WT and Washc1ΔHep mice as determined by targeted proteomics (n = 6). (C) HDL protein (125I) and HDL-C (3H) plasma decay in male WT and Washc1ΔHep mice (n = 6–7). (D) Fractional catabolic rate of plasma HDL holoparticle (125I), HDL-C (3H), and selective HDL-C clearance (3H–125I) of male WT and Washc1ΔHep mice. (E) HDL holoparticle (125I), HDL-C (3H), and selective HDL cholesterol uptake (3H–125I) in liver of male WT and Washc1ΔHep mice (n = 6–7). Data are presented as the mean ± SEM, *P < 0.05, **P < 0.01, as determined by Student’s t test.

Copyright © 2022 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts